Abstract
Muse cells are recently found endogenous non-tumorigenic pluripotent stem cells that reside in connective tissue of various organs including the dermis and in the bone marrow. They are collectable as cells positive for stage-specific embryonic antigen (SSEA)-3, a pluripotent surface marker, from tissues, and are expandable in vitro. Other than SSEA-3, they express Oct3/4, Nanog and Sox, other pluripotent genes. Notably, they are able to differentiate into cells representative of all three germ layers from single cells and are self-renewable, suggesting their pluripotency. Muse cells collected from human dermal fibroblasts (dermal-Muse cells) were shown to efficiently differentiate into melanin-producing functional melanocytes by treating them with ten factors. Functions of melanocytes induced from Muse cells (Muse melanocytes) were comparable to that of primary human melanocytes. Melanin-producing ability of human Muse melanocytes was retained when they were incorporated into human-colored three-dimensional (3D) cultured skin and even after transplantation of the 3D-cultured skin into the back of immunodeficient mice. Since Muse cells are non-tumorigenic and harvestable from easy accessible sources such as skin biopsy and dermal fibroblasts, Muse melanocytes are beneficial for both industrial and clinical uses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fioramonti P, Onesti MG, Marchese C, Carella S, Ceccarelli S, Scuderi N. Autologous cultured melanocytes in vitiligo treatment comparison of two techniques to prepare the recipient site: erbium-doped yttrium aluminum garnet laser versus dermabrasion. Dermatol Surg. 2012;38(5):809–12. https://doi.org/10.1111/j.1524-4725.2012.02354.x.
van Geel N, Ongenae K, Naeyaert JM. Surgical techniques for vitiligo: a review. Dermatology. 2001;202(2):162–6. https://doi.org/10.1159/000051626.
Fang D, Leishear K, Nguyen TK, Finko R, Cai K, Fukunaga M, et al. Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells. 2006;24(7):1668–77. https://doi.org/10.1634/stemcells.2005-0414.
Motohashi T, Aoki H, Yoshimura N, Kunisada T. Induction of melanocytes from embryonic stem cells and their therapeutic potential. Pigment Cell Res. 2006;19(4):284–9. https://doi.org/10.1111/j.1600-0749.2006.00317.x.
Nissan X, Larribere L, Saidani M, Hurbain I, Delevoye C, Feteira J, et al. Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis. Proc Natl Acad Sci U S A. 2011;108(36):14861–6. https://doi.org/10.1073/pnas.1019070108.
Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, et al. Generation of human melanocytes from induced pluripotent stem cells. PLoS One. 2011;6(1):e16182. https://doi.org/10.1371/journal.pone.0016182.
Yamane T, Hayashi S, Mizoguchi M, Yamazaki H, Kunisada T. Derivation of melanocytes from embryonic stem cells in culture. Dev Dyn. 1999;216(4–5):450–8. https://doi.org/10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0.
Yang R, Jiang M, Kumar SM, Xu T, Wang F, Xiang L, et al. Generation of melanocytes from induced pluripotent stem cells. J Invest Dermatol. 2011;131(12):2458–66. https://doi.org/10.1038/jid.2011.242.
Knoppers BM, Bordet S, Isasi R. The human embryo: ethical and legal aspects. Methods Mol Biol. 2009;550:281–305. https://doi.org/10.1007/978-1-60327-009-0_18.
Manzar N, Manzar B, Hussain N, Hussain MF, Raza S. The ethical dilemma of embryonic stem cell research. Sci Eng Ethics. 2013;19(1):97–106. https://doi.org/10.1007/s11948-011-9326-7.
Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11(4):268–77. https://doi.org/10.1038/nrc3034.
Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem. 2010;111(4):769–81. https://doi.org/10.1002/jcb.22775.
Goldring CE, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell. 2011;8(6):618–28. https://doi.org/10.1016/j.stem.2011.05.012.
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313–7. https://doi.org/10.1038/nature05934.
Paino F, Ricci G, De Rosa A, D’Aquino R, Laino L, Pirozzi G, et al. Ecto-mesenchymal stem cells from dental pulp are committed to differentiate into active melanocytes. Eur Cell Mater. 2010;20:295–305.
Stevens A, Zuliani T, Olejnik C, LeRoy H, Obriot H, Kerr-Conte J, et al. Human dental pulp stem cells differentiate into neural crest-derived melanocytes and have label-retaining and sphere-forming abilities. Stem Cells Dev. 2008;17(6):1175–84. https://doi.org/10.1089/scd.2008.0012.
Heneidi S, Simerman AA, Keller E, Singh P, Li X, Dumesic DA, et al. Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One. 2013;8(6):e64752. https://doi.org/10.1371/journal.pone.0064752.
Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A. 2010a;107(19):8639–43. https://doi.org/10.1073/pnas.0911647107. 0911647107 [pii].
Kuroda Y, Wakao S, Kitada M, Murakami T, Nojima M, Dezawa M. Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc. 2013;8(7):1391–415. https://doi.org/10.1038/nprot.2013.076.
Liu Q, Zhang RZ, Li D, Cheng S, Yang YH, Tian T, et al. Muse cells, a new type of pluripotent stem cell derived from human fibroblasts. Cell Reprogram. 2016;18(2):67–77. https://doi.org/10.1089/cell.2015.0085.
Ogura F, Wakao S, Kuroda Y, Tsuchiyama K, Bagheri M, Heneidi S, et al. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev. 2014;23(7):717–28. https://doi.org/10.1089/scd.2013.0473.
Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H, et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci U S A. 2011;108(24):9875–80. https://doi.org/10.1073/pnas.1100816108.
Dezawa M. Muse cells provide the pluripotency of mesenchymal stem cells: direct contribution of Muse cells to tissue regeneration. Cell Transplant. 2016. https://doi.org/10.3727/096368916X690881.
Gage FH. Mammalian neural stem cells. Science. 2000;287(5457):1433–8.
Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood. 2008;112(9):3543–53. https://doi.org/10.1182/blood-2008-08-078220.
Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.
Kuroda Y, Kitada M, Wakao S, Dezawa M. Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells? Arch Immunol Ther Exp. 2011;59(5):369–78. https://doi.org/10.1007/s00005-011-0139-9.
Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22(3):377–84. https://doi.org/10.1634/stemcells.22-3-377.
Qayyum AA, Haack-Sorensen M, Mathiasen AB, Jorgensen E, Ekblond A, Kastrup J. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med. 2012;7(3):421–8. https://doi.org/10.2217/rme.12.17.
Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, Takeda S, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science. 2005;309(5732):314–7. https://doi.org/10.1126/science.1110364.
Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284(5417):1168–70.
Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest. 2004;113(12):1701–10. https://doi.org/10.1172/JCI20935.
Dezawa M, Takahashi I, Esaki M, Takano M, Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci. 2001;14(11):1771–6.
Kingham PJ, Kalbermatten DF, Mahay D, Armstrong SJ, Wiberg M, Terenghi G. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol. 2007;207(2):267–74. https://doi.org/10.1016/j.expneurol.2007.06.029. S0014-4886(07)00257-9 [pii].
Fox NW, Damjanov I, Knowles BB, Solter D. Stage-specific embryonic antigen 3 as a marker of visceral extraembryonic endoderm. Dev Biol. 1984;103(1):263–6.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.
Galderisi U, Giordano A. The gap between the physiological and therapeutic roles of mesenchymal stem cells. Med Res Rev. 2014;34(5):1100–26. https://doi.org/10.1002/med.21322.
Hori E, Hayakawa Y, Hayashi T, Hori S, Okamoto S, Shibata T, et al. Mobilization of pluripotent multilineage-differentiating stress-enduring cells in ischemic stroke. J Stroke Cerebrovasc Dis. 2016. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.12.033.
Kinoshita K, Kuno S, Ishimine H, Aoi N, Mineda K, Kato H, et al. Therapeutic potential of adipose-derived SSEA-3-positive muse cells for treating diabetic skin ulcers. Stem Cells Transl Med. 2015;4(2):146–55. https://doi.org/10.5966/sctm.2014-0181.
Uchida H, Morita T, Niizuma K, Kushida Y, Kuroda Y, Wakao S, et al. Transplantation of unique subpopulation of fibroblasts, muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells. 2016;34(1):160–73. https://doi.org/10.1002/stem.2206.
Tsuchiyama K, Wakao S, Kuroda Y, Ogura F, Nojima M, Sawaya N, et al. Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts. J Invest Dermatol. 2013;133(10):2425–35. https://doi.org/10.1038/jid.2013.172.
Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K, et al. A distinct subpopulation of bone marrow mesenchymal stem cells, muse cells, directly commit to the replacement of liver components. Am J Transplant. 2016;16(2):468–83. https://doi.org/10.1111/ajt.13537.
Yamauchi T, Kuroda Y, Morita T, Shichinohe H, Houkin K, Dezawa M, et al. Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One. 2015;10(3):e0116009. https://doi.org/10.1371/journal.pone.0116009.
Dong L, Li Y, Cao J, Liu F, Pier E, Chen J, et al. FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription. Cell Death Differ. 2012;19(4):616–22. https://doi.org/10.1038/cdd.2011.132.
Kondo T, Hearing VJ. Update on the regulation of mammalian melanocyte function and skin pigmentation. Expert Rev Dermatol. 2011;6(1):97–108. https://doi.org/10.1586/edm.10.70.
Steingrimsson E, Copeland NG, Jenkins NA. Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet. 2004;38:365–411. https://doi.org/10.1146/annurev.genet.38.072902.092717.
Lee SA, Son YO, Kook SH, Choi KC, Lee JC. Ascorbic acid increases the activity and synthesis of tyrosinase in B16F10 cells through activation of p38 mitogen-activated protein kinase. Arch Dermatol Res. 2011;303(9):669–78. https://doi.org/10.1007/s00403-011-1158-4.
Motohashi T, Aoki H, Chiba K, Yoshimura N, Kunisada T. Multipotent cell fate of neural crest-like cells derived from embryonic stem cells. Stem Cells. 2007;25(2):402–10. https://doi.org/10.1634/stemcells.2006-0323.
Toma JG, McKenzie IA, Bagli D, Miller FD. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells. 2005;23(6):727–37. https://doi.org/10.1634/stemcells.2004-0134.
Fernandes KJ, McKenzie IA, Mill P, Smith KM, Akhavan M, Barnabe-Heider F, et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol. 2004;6(11):1082–93. https://doi.org/10.1038/ncb1181.
Joannides A, Gaughwin P, Schwiening C, Majed H, Sterling J, Compston A, et al. Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells. Lancet. 2004;364(9429):172–8. https://doi.org/10.1016/S0140-6736(04)16630-0.
Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol. 2001;3(9):778–84. https://doi.org/10.1038/ncb0901-778.
Li L, Fukunaga-Kalabis M, Yu H, Xu X, Kong J, Lee JT, et al. Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci. 2010;123.(Pt 6:853–60. https://doi.org/10.1242/jcs.061598.
Yu H, Fang D, Kumar SM, Li L, Nguyen TK, Acs G, et al. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol. 2006;168(6):1879–88. https://doi.org/10.2353/ajpath.2006.051170.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dezawa, M., Tsuchiyama, K., Yamazaki, K., Aiba, S. (2019). Regenerating Melanocytes: Current Stem Cell Approaches with Focus on Muse Cells. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Cham. https://doi.org/10.1007/978-3-319-62960-5_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-62960-5_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62958-2
Online ISBN: 978-3-319-62960-5
eBook Packages: MedicineMedicine (R0)